Spruce Biosciences Inc.

NASDAQ: SPRB · Real-Time Price · USD
8.75
-0.55 (-5.93%)
At close: Jun 09, 2025, 3:57 PM
8.75
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT

Spruce Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
25.61M 38.75M 60.05M 69.68M 81.15M 96.34M 98.8M 97.48M 73.93M 24.49M 21.65M 47.21M 23.34M 42.75M 58.36M 78.28M 148.63M
Short-Term Investments
n/a n/a n/a n/a n/a n/a 9.23M 23.04M 44.66M 54.59M 68.75M 46.09M 68M 46.22M 33.96M 30.95M n/a
Long-Term Investments
n/a n/a n/a n/a 35K 35K 34K 34K 29K 129K 216K 5.8M 17.6M 32.46M 38.98M 29.77M 216K
Other Long-Term Assets
204K 69K 531K 547K 518K 547K 573K 502K 496K 511K 667K 890K 894K 653K 631K 673K 473K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a 15M n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a 3.4M n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
2.06M 2.28M 860K 1.53M 1.61M 1.97M 419K 206K 253K 1.21M 2.79M 390K 325K 396K 301K 347K 272K
Total Current Assets
30.58M 44.21M 63.57M 73.91M 85.86M 102.18M 111.14M 124.13M 137.24M 83.61M 93.19M 96.51M 95.1M 91.89M 93.92M 111.37M 151.59M
Property-Plant & Equipment
869K 934K 998K 1.06M 1.12M 1.18M 1.24M 1.3M 1.35M 1.4M 1.23M 1.31M 1.4M 1.48M 1.56M 1.64M 1.72M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.07M 1M 1.53M 1.61M 1.67M 1.76M 1.85M 1.83M 1.88M 2.04M 2.11M 8.01M 19.89M 34.59M 41.16M 32.08M 2.4M
Total Assets
31.65M 45.21M 65.1M 75.52M 87.54M 103.95M 112.98M 125.96M 139.11M 85.65M 95.3M 104.52M 114.99M 126.49M 135.09M 143.45M 153.99M
Account Payables
1.88M 1.29M 1.8M 682K 1.89M 3.33M 3.15M 945K 3.45M 1.43M 2.18M 1.45M 1.11M 2.82M 2.13M 1.11M 2.57M
Deferred Revenue
n/a n/a 697K 1.3M 2.91M 4.91M 7.8M 8.06M 9.21M n/a n/a -380K n/a -360K 1.04M n/a n/a
Short-Term Debt
1.34M 1.62M 1.62M 1.62M 1.62M 1.62M 1.62M 1.62M 1.62M 1.62M 1.22M 811K 405K n/a n/a n/a n/a
Other Current Liabilities
1.52M 882K 2.22M 8.68M 10.13M 11.25M 8.94M 10.19M 7.49M n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
15.67M 15.25M 11.86M 14.29M 18.39M 24.46M 24.19M 22.73M 23M 12.45M 12M 10.1M 8.97M 8.87M 9.06M 6.98M 6.85M
Long-Term Debt
n/a 124K 524K 923K 1.32M 1.72M 2.11M 2.51M 2.9M 3.29M 3.69M 4.08M 4.49M 4.88M 4.87M 4.86M 4.84M
Other Long-Term Liabilities
n/a 282K 273K 262K 250K 236K 220K 202K 181K 161K 139K 117K 95K 73K 51K 29K 8K
Total Long-Term Liabilities
659K 1.14M 1.61M 2.06M 2.52M 2.97M 3.42M 6.67M 8.12M 4.71M 4.82M 5.29M 5.78M 6.24M 6.31M 6.36M 6.42M
Total Liabilities
16.32M 16.39M 13.46M 16.35M 20.91M 27.44M 27.6M 29.4M 31.12M 17.16M 16.82M 15.39M 14.74M 15.12M 15.37M 13.34M 13.27M
Total Debt
2.29M 2.77M 3.23M 3.69M 4.15M 4.61M 5.06M 5.28M 5.73M 6.32M 6.29M 6.37M 6.46M 6.17M 6.61M 6.67M 6.74M
Common Stock
4K 4K 4K 4K 4K 4K 4K 4K 4K 3K 3K 3K 3K 3K 3K 3K 2K
Retained Earnings
-264.31M -250.27M -226.71M -218.04M -208.86M -197.23M -187.28M -174.93M -162.1M -149.31M -138.17M -126.77M -114.89M -103.13M -93.95M -82.5M -70.73M
Comprehensive Income
n/a n/a n/a n/a 0.00 -0.00 -3K -55K -188K -558K -873K -845K -693K -184K -16K -29K -0.00
Shareholders Equity
15.32M 28.82M 51.64M 59.17M 66.62M 76.51M 85.38M 96.56M 108M 68.49M 78.47M 89.12M 100.24M 111.37M 119.72M 130.11M 140.72M
Total Investments
n/a n/a n/a 35K 35K 35K 9.23M 23.04M 44.66M 54.59M 68.75M 51.89M 85.61M 78.68M 72.93M 60.71M 216K